Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Stief

Showing results (191-200 of 236) with videos related to

Pageof 24
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2018
Outcome after PSMA PET/CT based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a bi-institutional retrospective analysisNina-Sophie Schmidt-Hegemann, Christian Stief, Tak-Hyun Kim, et al.
Scientific Reports|March 22, 2022
Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsyAlexander Kretschmer, Holger Kajau, Eric Margolis, et al.
European Urology Oncology|December 31, 2025
Multiregional Immune Profiling Reveals Prognostic Patterns in Bladder CancerNadia Jurczok, Gabriel Dernbach, Benedikt Ebner, et al.
World Journal of Urology|August 21, 2012
Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective seriesSabine Brookman-May, Matthias May, Vincenzo Ficarra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 2, 2023
An Analysis of the Distribution of PSMA PET/CT-Positive Lymph Nodes and Their Coverage by Different Elective Nodal Radiation Volumes in Postoperative Prostate Cancer PatientsChristian Trapp, Dmytro Oliinyk, Paul Rogowski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2026
PET-Based Outcome Prediction in Patients with Prostate Cancer Scheduled for [<sup>225</sup>Ac]Ac-PSMA Radiopharmaceutical TherapyLiam Widjaja, Sophie C Siegmund, Franz J Gildehaus, et al.
International Journal of Clinical Oncology|September 1, 2019
External validation of a postoperative nomogram for the prediction of disease-specific survival in patients with papillary renal cell carcinoma using a large multicenter databaseStefan Zastrow, Laura-Maria Krabbe, Ingmar Wolff, et al.
European Urology Focus|July 30, 2017
Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?Umberto Capitanio, Grant D Stewart, Tobias Klatte, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 11, 2026
Effects of androgen receptor signaling inhibitors on absorbed doses in mCRPC patients undergoing [<sup>177</sup>Lu]Lu-PSMA-617 or [<sup>177</sup>Lu]Lu-PSMA-I&T therapy: dosimetry resultsJosef Zahner, Astrid Delker, Zachary Ells, et al.
Psycho-Oncology|August 2, 2019
Factors associated with the decline of psychological support in hospitalized patients with cancerTheresia Pichler, Andreas Dinkel, Birgitt Marten-Mittag, et al.
Pageof 24

Showing results (191-200 of 236) with videos related to

Sort By:
Pageof 24
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2018
Outcome after PSMA PET/CT based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a bi-institutional retrospective analysisNina-Sophie Schmidt-Hegemann, Christian Stief, Tak-Hyun Kim, et al.
Scientific Reports|March 22, 2022
Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsyAlexander Kretschmer, Holger Kajau, Eric Margolis, et al.
European Urology Oncology|December 31, 2025
Multiregional Immune Profiling Reveals Prognostic Patterns in Bladder CancerNadia Jurczok, Gabriel Dernbach, Benedikt Ebner, et al.
World Journal of Urology|August 21, 2012
Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective seriesSabine Brookman-May, Matthias May, Vincenzo Ficarra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 2, 2023
An Analysis of the Distribution of PSMA PET/CT-Positive Lymph Nodes and Their Coverage by Different Elective Nodal Radiation Volumes in Postoperative Prostate Cancer PatientsChristian Trapp, Dmytro Oliinyk, Paul Rogowski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2026
PET-Based Outcome Prediction in Patients with Prostate Cancer Scheduled for [<sup>225</sup>Ac]Ac-PSMA Radiopharmaceutical TherapyLiam Widjaja, Sophie C Siegmund, Franz J Gildehaus, et al.
International Journal of Clinical Oncology|September 1, 2019
External validation of a postoperative nomogram for the prediction of disease-specific survival in patients with papillary renal cell carcinoma using a large multicenter databaseStefan Zastrow, Laura-Maria Krabbe, Ingmar Wolff, et al.
European Urology Focus|July 30, 2017
Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?Umberto Capitanio, Grant D Stewart, Tobias Klatte, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 11, 2026
Effects of androgen receptor signaling inhibitors on absorbed doses in mCRPC patients undergoing [<sup>177</sup>Lu]Lu-PSMA-617 or [<sup>177</sup>Lu]Lu-PSMA-I&T therapy: dosimetry resultsJosef Zahner, Astrid Delker, Zachary Ells, et al.
Psycho-Oncology|August 2, 2019
Factors associated with the decline of psychological support in hospitalized patients with cancerTheresia Pichler, Andreas Dinkel, Birgitt Marten-Mittag, et al.
Pageof 24